Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von conna 

Oracle Corp. diskutieren

Oracle Corp.

WKN: 871460 / Symbol: ORCL / Name: Oracle / Aktie / Software & Informationsdienstleistungen / Large Cap /

131,24 €
-0,03 %

Einschätzung Buy
Rendite (%) 6,55 %
Kursziel 152,36
Veränderung
Endet am 12.06.25

Oracle Co. (NYSE: ORCL) had its price target raised by analysts at TD Cowen from $145.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for ORCL provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,16 %
Kursziel 147,73
Veränderung
Endet am 12.06.25

Oracle Co. (NYSE: ORCL) had its price target raised by analysts at UBS Group AG from $150.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for ORCL provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,16 %
Kursziel 147,73
Veränderung
Endet am 12.06.25

Oracle Co. (NYSE: ORCL) had its price target raised by analysts at Evercore ISI from $145.00 to $160.00. They now have an "outperform" rating on the stock.
Ratings data for ORCL provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,40 %
Kursziel 157,68
Veränderung
Endet am 12.06.25

Oracle Co. (NYSE: ORCL) had its price target raised by analysts at Sanford C. Bernstein from $159.00 to $171.00. They now have an "outperform" rating on the stock.
Ratings data for ORCL provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,93 %
Kursziel 158,63
Veränderung
Endet am 17.06.25

Oracle Co. (NYSE: ORCL) had its price target raised by analysts at Mizuho from $160.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for ORCL provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,49 %
Kursziel 153,95
Veränderung
Endet am 17.06.25

Oracle Co. (NYSE: ORCL) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $150.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for ORCL provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,05 %
Kursziel 147,90
Veränderung
Endet am 18.06.25

Oracle Co. (NYSE: ORCL) had its price target raised by analysts at Argus from $145.00 to $159.00. They now have a "buy" rating on the stock.
Ratings data for ORCL provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,79 %
Kursziel 163,35
Veränderung
Endet am 25.06.25

Oracle Co. (NYSE: ORCL) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $175.00 price target on the stock.
Ratings data for ORCL provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,46 %
Kursziel 145,00
Veränderung
Endet am 26.06.25

Oracle is an impressive tech giant that continues to innovate and expand its reach, especially in the healthcare sector. The recent launch of their Oracle Health Insurance Data Exchange Cloud Service is a game-changer, and I believe it will drive long-term growth for the company. Additionally, the availability of their HeatWave GenAI technology for general use is a testament to Oracle's commitment to staying at the forefront of the AI revolution. While there may be some short-term challenges, such as the potential impact of TikTok, I'm confident that Oracle's solid fundamentals and forward-thinking strategy will translate into strong performance in the long run. It's a tech stock worth considering for your portfolio.

Einschätzung Buy
Rendite (%) 0,83 %
Kursziel 145,00
Veränderung
Endet am 26.06.25

Oracle is making strategic moves to expand its healthcare offerings and leverage cutting-edge technologies like AI, which could drive long-term growth. Despite some near-term headwinds like the potential impact of TikTok, the company's strong fundamentals and forward-looking initiatives make it an attractive investment opportunity.

Einschätzung Buy
Rendite (%) 0,04 %
Kursziel 145,00
Veränderung
Endet am 27.06.25

Oracle's recent expansion into the healthcare sector and the release of its HeatWave GenAI technology have me excited about the company's long-term growth prospects. While the potential TikTok ban could pose a short-term challenge, I believe Oracle's diversified business model and strong market position will help it weather the storm. It's like a seasoned athlete facing a tough opponent - with the right strategy and determination, they can come out on top. I'm optimistic that Oracle will continue to innovate and capitalize on emerging trends in the tech industry, making it a compelling investment opportunity.

Einschätzung Buy
Rendite (%) -1,59 %
Kursziel 150,00
Veränderung
Endet am 04.07.25

Oracle is making some exciting moves in the realm of generative AI and database technology, which could give them a competitive edge. While there are some concerns around their licensing practices, the overall outlook seems positive. Their expansion into the healthcare sector also presents promising long-term growth opportunities. As an investor, I'm optimistic about Oracle's potential to capitalize on emerging trends and deliver solid returns.

Einschätzung Buy
Rendite (%) -1,59 %
Kursziel 150,00
Veränderung
Endet am 04.07.25

Oracle's latest innovations in generative AI and database technologies position the company well for future growth. While some concerns around licensing practices and potential TikTok ban impacts exist, Oracle's diversified business model and strong track record make it an attractive long-term investment. The company's expansion into healthcare also presents an exciting growth opportunity. Overall, I'm bullish on Oracle's prospects and believe the stock is poised to outperform the market in the coming year.

Einschätzung Buy
Rendite (%) -1,61 %
Kursziel 145,00
Veränderung
Endet am 04.07.25

Oracle's recent announcements regarding their groundbreaking database-integrated large language models (LLMs) and automated database-embedded vector storage with HeatWave GenAI showcase the company's commitment to driving innovation in the tech industry. This, combined with their expansion into the healthcare sector, paints a promising picture for Oracle's long-term growth prospects. While there are concerns about the potential impact of a TikTok ban on the company, Oracle's diversified business model and strong position in the enterprise software market make it a solid investment opportunity. With a target price of $145, I believe Oracle is well-positioned to deliver attractive returns to investors in the coming months.

Einschätzung Buy
Rendite (%) -1,33 %
Kursziel 145,00
Veränderung
Endet am 08.07.25

Oracle Corp. seems to be on a roll lately, with the company making some exciting moves that could drive future growth. The recent news about the company's OTCQB listing upgrade and its foray into the crypto space with the launch of an innovative index fund are particularly promising developments. Additionally, the merger between Paramount Global and Skydance Media, led by the son of Oracle's founder, could open up new opportunities for the tech giant. While the current stock price of $133.46 may seem a bit high, I believe the long-term potential of Oracle makes it a solid investment. The company's strong financials, innovative products, and strategic partnerships suggest that it's well-positioned to capitalize on emerging trends in the tech industry. I'm optimistic that Oracle can continue to deliver solid returns for investors in the months and years ahead.

Einschätzung Buy
Rendite (%) 1,00 %
Kursziel 145,00
Veränderung
Endet am 11.07.25

Oracle's strong cloud business and strategic partnerships are driving impressive growth. The company's diversified product portfolio and robust cloud infrastructure position it well for the future. While market conditions remain challenging, Oracle's resilience and innovative solutions make it an attractive investment option at the current price level.

Einschätzung Buy
Rendite (%) -0,92 %
Kursziel 137,52
Veränderung
Endet am 12.07.25

Oracle Co. (NYSE: ORCL) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $150.00 price target on the stock.
Ratings data for ORCL provided by MarketBeat